Treatment for the Mental Health Impact of Killing in War

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01406834
First received: July 19, 2011
Last updated: May 16, 2013
Last verified: May 2013

July 19, 2011
May 16, 2013
October 2011
January 2013   (final data collection date for primary outcome measure)
Change in psychological symptoms as measured by the Symptom Checklist-90 (SCL-90-R) [ Time Frame: Measured at baseline and study completion (week 7) ] [ Designated as safety issue: No ]
A brief multidimensional self-report inventory that screens for nine symptoms of psychopathology and provides three global distress indicators.
Same as current
Complete list of historical versions of study NCT01406834 on ClinicalTrials.gov Archive Site
Change in killing-related maladaptive cognitions as measured by the Killing Cognitions Scale (KCS) [ Time Frame: Measured at baseline and study completion (week 7) ] [ Designated as safety issue: No ]
Assesses killing-related maladaptive cognitions
Same as current
Not Provided
Not Provided
 
Treatment for the Mental Health Impact of Killing in War
Treatment for the Mental Health Impact of Killing in War: Augmentation of Existing Evidence-Based Mental Health Interventions

The goal of this project is to test the feasibility, acceptability, and efficacy of a treatment module addressing the mental health and functional impact of killing in the war zone.

The investigators will enroll between 12-20 Veterans who have killed in war and have been diagnosed with post-traumatic stress disorder (PTSD) for a pilot study assessing the efficacy of the six-session treatment. Veterans will be randomized either to the treatment or to the waitlist control group.

Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Combat veterans

Posttraumatic Stress Disorder (PTSD)
Behavioral: Impact of Killing CBT Treatment
Treatment will include six, one hours sessions with a licensed clinical psychologist or an advanced postdoctoral fellow under the close supervision of a licensed psychologist.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
8
Not Provided
January 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of PTSD
  • Veteran will need to endorse having taken another life in a war zone context
  • Have received some prior evidence-based treatment for PTSD

Exclusion Criteria:

  • Meet current or lifetime criteria for a psychotic disorder
  • Participants in current PTSD treatment will not be excluded;however,if receiving medications they will need to be stabilized on current medications for at least one month.
  • If receiving Prolonged Exposure Therapy or Cognitive Behavioral Therapy, individuals will need to wait two weeks after they have completed the treatment to enroll in the study.
Both
18 Years to 70 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01406834
11-06004
No
University of California, San Francisco
University of California, San Francisco
Department of Veterans Affairs
Principal Investigator: Shira Maguen, PhD University of California San Francisco/ San Francisco VA Medical Center
University of California, San Francisco
May 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP